Want to join the conversation?
Product sales for $BIIB increased 6% YoverY to $2.3Bil in 1Q16. Worldwide TECFIDERA revenue grew 15% YoverY to $946MM. Interferon, which includes AVONEX and PLEGRIDY, fell to 11% to $670MM, while Avonex fell 19% to $564MM. Meanwhile, revenue from PLEGRIDY rose 72% to $106MM.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!